HB 3533

  • Illinois House Bill
  • 102nd Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Naloxone Information

Abstract

Amends the Illinois Controlled Substances Act. Provides that a prescriber shall provide information to all patients receiving a prescription for opioids on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression.

Bill Sponsors (2)

Votes


No votes to display

Actions


Jan 10, 2023

House

Session Sine Die

Apr 23, 2021

House

Rule 19(a) / Re-referred to Rules Committee

Apr 21, 2021

House

Held on Calendar Order of Second Reading - Short Debate

House

Second Reading - Short Debate

Apr 08, 2021

House

Placed on Calendar 2nd Reading - Short Debate

Mar 26, 2021

House

Do Pass / Short Debate Mental Health & Addiction Committee; 016-000-000

Mar 16, 2021

House

Assigned to Mental Health & Addiction Committee

Mar 11, 2021

House

Added Co-Sponsor Rep. Kambium Buckner

Feb 22, 2021

House

Referred to Rules Committee

House

First Reading

Feb 19, 2021

House

Filed with the Clerk by Rep. Deb Conroy

Bill Text

Bill Text Versions Format
Introduced HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.